Indoco Remedies receives USFDA approval for Rasagiline tablets

Indoco Remedies on has received USFDA approval for Rasagiline tablets which are used for the treatment of Parkinson’s disease. The prescribed drug will be made available in strengths of 0.5 mg and 1 mg. According to market estimates, the market size of Rasagiline tablets in the US is USD 105 million. It may be noted that, the company has 32 ANDAs pending for approval for different dosage forms. It is likely the company will produce this drug from its Goa plant.

Company Profile : Indoco Remedies Ltd

Be the first to comment

Leave a Reply

Your email address will not be published.